According to The Insight Partners, “Women Healthcare Market Size, Share, Growth, Trends and Global Forecast to 2028 – COVID-19 Impact and Global Analysis By Drug (EVISTA, XGEVA, Prolia, Mirena, Zometa, Reclast/Aclasta, and Others), Application (Hormonal Infertility, Postmenopausal Osteoporosis, Endometriosis, Contraceptives, Menopause, and Others), and Geography”; the global women healthcare market is expected to grow at a CAGR of 4.8% between 2022 and 2028, it was valued at USD 30.5 billion in 2021 and is likely to reach USD 42.8 billion by 2028.
Download PDF Brochure: https://www.theinsightpartners.com/sample/TIPRE00024010
Bayer AG, Allergan plc, Merck & Co., Pfizer Inc., Amgen Inc., Agile Therapeutics Inc., Ferring Pharmaceuticals, Mylan N.V., Lupin Limited, and Blairex Laboratories are among the key players profiled during the study of the women healthcare market. Several other major companies were studied and analyzed during this research study to get a holistic view of the market and its ecosystem.
Key players involved in the women healthcare market are undertaking initiatives to extend their product portfolios and strengthen their market position. For instance, in May 2022, Emcure, FOGSI launched an awareness campaign, “EmWocal,” on women’s health in association with the Federation of Obstetrics and Gynaecologists of India (FOGSI). The initiative was live at 8000 clinics, presented in nine languages across India, and aimed to reach one crore women. Additionally, in April 2018, Mylan N.V. announced the US launch of Drospirenone and Ethinyl Estradiol tablets, a generic version of Bayer’s Yaz Tablets. This product is indicated for use by women to prevent pregnancy and for the treatment of acne vulgaris in women at least 14 years of age who have achieved menarche and desire an oral contraceptive for birth control.
Inquiry Before Purchase: https://www.theinsightpartners.com/inquiry/TIPRE00024010
Women’s health directs to the branch of medicine that focuses on treating and diagnosing diseases and conditions affecting women’s physical and emotional well-being. Women usually experience unique health care challenges and are more likely to be diagnosed with certain diseases than men. Chronic diseases and conditions such as heart disease, cancer, and diabetes are the leading causes of death among women. Other health concerns impacting women include maternal health issues, urinary tract infections, sexual health, and osteoporosis.
According to the World Health Organization (WHO), as of August 2022, there were 596,873,121 confirmed cases of COVID-19 and 6,459,684 deaths. The highest number of deaths was in the Americas, followed by Europe and Southeast Asia. Due to economic uncertainty caused by COVID-19, limited transit options and travel limitations created impediments to international trade and transportation, affecting the supply chain for women’s health diagnostics and temporarily lowering demand. The COVID-19 pandemic disrupted the supply chain of contraceptives, thus affecting sexual and reproductive health services. Also, due to COVID-19, several health services was forced to suspended or postponed. Thus, during the initial days, the COVID-19 pandemic had a negative impact on the women healthcare market.
Purchase Premium Copy of Women Healthcare Market Growth Report (2022-2028) at: https://www.theinsightpartners.com/buy/TIPRE00024010
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sameer Joshi
Press Release: https://www.theinsightpartners.com/pr/women-health-care-market